COMMISSIONED EQUITY RESEARCH
PROLIGHT: Pre-validation readout in Q4 sets stage for multicenter trial in 2025
Read More Read Less
COMMISSIONED EQUITY RESEARCH
Prolight Diagnostics: SEK 17m UK grant a welcome external validation
Read More Read Less
COMMISSIONED EQUITY RESEARCH
PROLIGHT: Important milestone amidst mixed news flow
Read More Read Less
COMMISSIONED EQUITY RESEARCH
PROLIGHT: PoC troponin testing ready for next step
Read More Read Less